All News

Rituximab vs. JAK inhibitors in Rheumatoid Lung Disease

Save

d Jack Cush, MD

Mar 19, 2021

There are no current FDA approved therapies for rheumatoid arthritis associated interstitial lung disease (RA-ILD) or bronchiectasis, but a recent retrospective cohort study showed equivalent outcomes when RA-ILD patients were treated with either rituximab or janus kinase inhibitors.

Read Article

RheumNow Podcast – Great Associations (3.19.2021)

Save

d Jack Cush, MD

Mar 18, 2021

Dr. Jack Cush rants on the journal reports, news and FDA actions featured this past week on RheumNow.com.

Read Article

Join me at the @RheumNow SpA session happening now! #rheumatology #spondyloarthritis #ankylosing https://t.co/CTLq0xWQys

Nigil Haroon MD, PhD 💎🦜🌎🩺🔬 NigilHaroon ( View Tweet)

Mar 21, 2021

Leading the Rheumatoid Arthritis pod with discussions on pneumonia and RA and interstitial lung disease in RA. #RNL2021 https://t.co/psxMTHsOva

Dr. John Cush RheumNow ( View Tweet)

Mar 20, 2021

New podcast available! Dr. Jack Cush rants on the journal reports, news and FDA actions featured this past week on RheumNow. https://t.co/rPnLp2NfRq https://t.co/TSTP2tWxXy

Links:

https://bit.ly/3r4fsvz

Dr. John Cush RheumNow ( View Tweet)

Mar 20, 2021

Our in-person participants engaging with the psoriatic panel #RNL2021 https://t.co/N0Cdos3Rhb

Dr. John Cush RheumNow ( View Tweet)

Mar 20, 2021

News Feature: Potent Topical Corticosteroids and the Risk of Osteoporotic Fractures https://t.co/KazNPRXKNx https://t.co/pykBdbexzF

Links:

https://bit.ly/3cD7gwY

Dr. John Cush RheumNow ( View Tweet)

Mar 20, 2021

@RheumNow #RNL2021 Dr. Buttgereit on steroids in RA: 2.5 mg/d of prednisone increase total steroid amount in the body by 100% - great therapeutic effect but comes w/plethora of side effects. Q: how do you feel out long term low dose steroids for RA?

Olga Petryna DrPetryna ( View Tweet)

Mar 20, 2021

Follow the hashtag #RNL2021 for all RheumNow Live coverage today and tomorrow!

Dr. John Cush RheumNow ( View Tweet)

Mar 20, 2021

RheumNow Live has started! #RNL2021 https://t.co/CrNqnnKqUy

Dr. John Cush RheumNow ( View Tweet)

Mar 20, 2021

Metanalysis reveals significant heterogeneity in defining Refractory Disease in RA and polyarticular JIA. Should include: 1) Resistance to multiple drugs w/ different MOAs (≥2bDMARDs) and 2) Persistent symptoms and disease activity https://t.co/CL6Mr3cs7J

Links:

https://bit.ly/3vDMkP4

Dr. John Cush RheumNow ( View Tweet)

Mar 20, 2021

News Feature: Are You a Super Rheum? https://t.co/LsGpFNXlkp https://t.co/Q9iojEQNqL

Links:

https://bit.ly/3c1bsaT

Dr. John Cush RheumNow ( View Tweet)

Mar 19, 2021

Top 4 arthritis types that significantly increase the risk of CVA: 1) RA (RR=1.38), 2) ankylosing spondylitis (RR=1.49), 3) psoriatic arthritis (RR=1.33) & gout (RR=1.4). With these, the risk was higher in younger (<45 yrs) (RR = 1.46), not older (>65) https://t.co/Snb6OrtZJH

Links:

https://bit.ly/3vDgBgX

Dr. John Cush RheumNow ( View Tweet)

Mar 19, 2021

NAFLD, NASH and Risks with DMARDs and MTX https://t.co/LYV9WycEjz https://t.co/Vx0jvhjCsd

Links:

https://bit.ly/3c7FAAe

Dr. John Cush RheumNow ( View Tweet)

Mar 19, 2021

Kiniksa announced Arcalyst (rilonacept) has been FDA-approved for the treatment of recurrent pericarditis. Rilonacept, an IL-1 inhibitor, also FDA approved for CAPS (Cryopyrin-Assoc Periodic Syndr) & DIRA (Defic IL-1 Recept Antag) https://t.co/erpiyuhsAv https://t.co/xp764WkWEI

Links:

Dr. John Cush RheumNow ( View Tweet)

Mar 19, 2021

News Feature: MDA-5 Antibodies and Juvenile Dermatomyositis https://t.co/vxyXZyO0gs https://t.co/GgzhnhlmdR

Links:

https://bit.ly/2NsvktY

Dr. John Cush RheumNow ( View Tweet)

Mar 19, 2021

SPIRIT‐P3 RCT treated biologic‐naive PsA with ixekizumab x36 wks; those w/ MDA x 3 mos were randomized to continue or withdraw IXE (blinded). There were significantly more relapses when IXE was stopped; most regained control when started https://t.co/lhQ8X1Ef48

Links:

https://bit.ly/3s1euRW

Dr. John Cush RheumNow ( View Tweet)

Mar 19, 2021

RCT shows Stepped Exercise Program to be effective in Knee Osteoarthritis. VAMC study of 345 knee OA pts given either STEP-KOA (internet based progr) or an arthritis education (control). WOMAC scores at 9 mos were 6.8 points lower in the STEP-KOA group.https://t.co/EuoPyJkTif

Links:

https://bit.ly/3bW4Yu3

Dr. John Cush RheumNow ( View Tweet)

Mar 19, 2021

There's still time to sign up. Attend RheumNow Live this weekend. We have a robust schedule planned with top professional. https://t.co/LJ3qClHTKh

Links:

https://bit.ly/3l5Fddm

Dr. John Cush RheumNow ( View Tweet)

Mar 18, 2021

Hydroxychloroquine studied vs Vitamin C (PBO) prophylaxis to households (n=671) exposed to COVID-19. 89% were COVD1-9 test neg at baseline. HCQ did not protect against progression to COVID (53 vs 45 events; adj HR, 1.10 [95% CI, 0.73 to 1.66]. A vit C Win! https://t.co/S5qjdIYaXq

Links: